NKX2-2突变导致先天性糖尿病和婴儿期肥胖,并伴有矛盾的葡萄糖诱导的胃饥饿素分泌
本文报告一例极低出生体重婴儿携带NKX2-2纯合移码变异c.356delG(p.P119fs64*),表现为严重新生儿糖尿病、1岁时已出现严重肥胖和发育迟缓;3.5岁口服葡萄糖耐量试验显示C肽不可测,胃饥饿素水平矛盾性升高30%。作者认为隐性NKX2-2功能丧失导致严重新生儿糖尿病,伴极低出生体重、儿童肥胖和发育迟缓,肥胖表型与餐后矛盾性胃饥饿素分泌相关,可能反映人类β细胞命运转向胃饥饿素分泌细胞。
要点
- NKX2-2纯合移码变异c.356delG(p.P119fs64*)可导致严重新生儿糖尿病,伴极低出生体重、儿童肥胖和发育迟缓。
- 极低出生体重婴儿血糖控制可采用每日3次长效胰岛素类似物方案。
- 3.5岁口服葡萄糖耐量试验显示C肽不可测,胃饥饿素水平矛盾性升高30%。
核心结论
- 隐性NKX2-2功能丧失导致严重新生儿糖尿病,伴极低出生体重、儿童肥胖和发育迟缓。
- 严重肥胖表型与餐后矛盾性胃饥饿素分泌相关,可能反映人类β细胞命运转向胃饥饿素分泌细胞。
研究设计与样本
- 病例报告:1例极低出生体重婴儿,表现为严重新生儿糖尿病,1岁时已出现严重肥胖和发育迟缓。
- 对已知新生儿糖尿病基因(如ABCC8、EIF2AK3)行Sanger测序,随后行全外显子组测序。
- 3.5岁时行口服葡萄糖耐量试验以阐明严重肥胖的原因。
主要发现
- 全外显子组测序发现胰岛细胞转录因子NKX2-2纯合致病性移码变异c.356delG,p.P119fs64*。
- 极低出生体重婴儿采用每日3次长效胰岛素类似物方案实现血糖控制。
- 3.5岁口服葡萄糖耐量试验显示C肽不可测,胃饥饿素水平矛盾性升高30%。
临床怎么用
- 作者认为隐性NKX2-2功能丧失是严重新生儿糖尿病的病因,应关注其伴随的极低出生体重、儿童肥胖和发育迟缓。
- 作者认为餐后矛盾性胃饥饿素分泌可能与严重肥胖表型相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: NKX2-2 is a crucial transcription factor that enables specific β-cell gene expression. Nkx2-2(-/-) mice manifest with severe neonatal diabetes and changes in β-cell progenitor fate into ghrelin-producing cells. In humans, recessive NKX2-2 gene mutations have been recently reported as a novel etiology for neonatal diabetes, with only 3 cases known worldwide. This study describes the genetic analysis, distinctive clinical features, the therapeutic challenges, and the unique pathophysiology causing neonatal diabetes in human NKX2-2 dysfunction. CASE DESCRIPTION: An infant with very low birth weight (VLBW) and severe neonatal diabetes (NDM) presented with severe obesity and developmental delay already at age 1 year. The challenge of achieving glycemic control in a VLBW infant was unexpectedly met by a regimen of 3 daily doses of long-acting insulin analogues. Sanger sequencing of known NDM genes (such as ABCC8 and EIF2AK3) was followed by whole-exome sequencing that revealed homozygosity of a pathogenic frameshift variant, c.356delG, p.P119fs64*, in the islet cells transcription factor, NKX2-2. To elucidate the cause for the severe obesity, an oral glucose tolerance test was conducted at age 3.5 years and revealed undetectable C-peptide levels with a paradoxically unexpected 30% increase in ghrelin levels. CONCLUSION: Recessive NKX2-2 loss of function causes severe NDM associated with VLBW, childhood obesity, and developmental delay. The severe obesity phenotype is associated with postprandial paradoxical ghrelin secretion, which may be related to human β-cell fate change to ghrelin-secreting cells, recapitulating the finding in Nkx2-2(-/-) mice islet cells.
引用
- Auerbach A, Cohen A, Ofek Shlomai N, et al. NKX2-2 Mutation Causes Congenital Diabetes and Infantile Obesity With Paradoxical Glucose-Induced Ghrelin Secretion. J Clin Endocrinol Metab. 2020. PMID: 32818257. doi:10.1210/clinem/dgaa563
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。